KRAS and cancer: Since BKA-073 is able to induce apoptosis by activation of Bak via facilitating its oligomerization in vitro and in vivo (Figures 1, 2 and 4), we were interested in testing whether BKA-073 is effective for the treatment of mutant KRAS-driven cancer.